Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Large-scale testing (Phase 3)Study completedNCT01038661
What this trial is testing

Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy

Who this might be right for
Lung Neoplasms
Sanofi 375
Testing effectiveness (Phase 2)Study completedNCT01156545
What this trial is testing

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

Who this might be right for
Non-small Cell Lung Cancer
National Cancer Center, Korea 68
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT00098462
What this trial is testing

Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00040885
What this trial is testing

Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)

Who this might be right for
AnorexiaCachexiaFatigue+1 more
Alliance for Clinical Trials in Oncology 67
Early research (Phase 1)Study completedNCT01114958
What this trial is testing

Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases

Who this might be right for
Lung NeoplasmsNeoplasm Metastasis
University of California, San Diego 8
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003589
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 450
Testing effectiveness (Phase 2)Study completedNCT00508625
What this trial is testing

AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

Who this might be right for
Non-Small Cell Lung Cancer
Amgen 213
Testing effectiveness (Phase 2)Looking for participantsNCT07198217
What this trial is testing

Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient

Who this might be right for
NSCLCTislelizumabChemotherapy+1 more
Zibo Municipal Hospital 20
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Large-scale testing (Phase 3)Ended earlyNCT00042315
What this trial is testing

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IIIb Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
QLT Inc. 490
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Large-scale testing (Phase 3)Ended earlyNCT00300885
What this trial is testing

Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small Cell Lung
Bayer 926
Testing effectiveness (Phase 2)Ended earlyNCT03087708
What this trial is testing

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology 50
Testing effectiveness (Phase 2)Study completedNCT03049618
What this trial is testing

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Who this might be right for
ALK Gene MutationBRAF Gene MutationEGFR Gene Mutation+9 more
University of Southern California 42
Early research (Phase 1)Study completedNCT00033410
What this trial is testing

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
California Cancer Consortium 30
Testing effectiveness (Phase 2)Study completedNCT00698815
What this trial is testing

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 130
Early research (Phase 1)Study completedNCT00876460
What this trial is testing

BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 43
Next Page